Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mol Immunol ; 46(4): 532-40, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18973947

RESUMEN

The prion protein, PrP, exists in several stable conformations, with the presence of one conformation, PrP(Sc), associated with transmissible neurodegenerative diseases. Targeting PrP by high-affinity ligands has been proven to be an effective way of preventing peripheral prion infections. Here, we have generated bacterially expressed single chain fragments of the variable domains (scFv) of a monoclonal antibody in Escherichia coli, originally raised against purified PrP(Sc) that recognizes both PrP(C) and PrP(Sc). This scFv fragment had a dissociation constant (K(D)) with recombinant PrP of 2 nM and cleared prions in ScN2a cells at 4 nM, as demonstrated by a mouse prion bioassay. A peptide corresponding to the complementarity determining region 3 of the heavy chain (CDR3H) selectively bound PrP(Sc) but had lost antiprion activity. However, synthesis and application of an improved peptide mimicking side chain topology of CDR3H while exhibiting increased protease resistance, a retro-inverso d-peptide of CDR3H, still bound PrP(Sc) and reinstated antiprion activity. We conclude that (1) scFvW226 is so far the smallest polypeptide with bioassay confirmed antiprion activity, and (2) differential conformation specificity and bioactivity can be regulated by orchestrating the participation of different CDRs.


Asunto(s)
Regiones Determinantes de Complementariedad/inmunología , Péptidos/inmunología , Proteínas PrPC/inmunología , Proteínas PrPSc/inmunología , Secuencia de Aminoácidos , Animales , Afinidad de Anticuerpos/inmunología , Línea Celular , Regiones Determinantes de Complementariedad/metabolismo , Ratones , Ratones Noqueados , Datos de Secuencia Molecular , Péptidos/química , Péptidos/metabolismo , Proteínas PrPC/metabolismo , Proteínas PrPSc/metabolismo , Conformación Proteica
2.
J Am Chem Soc ; 131(50): 18016-7, 2009 Dec 23.
Artículo en Inglés | MEDLINE | ID: mdl-19947644

RESUMEN

Paramagnetic relaxation enhancement (PRE) has become a useful and widely applied tool in biomolecular NMR spectroscopy. In particular investigations of large complexes or transient contacts benefit from PRE effects. Frequently such studies involve modification of the biomacromolecules under study. We here present a method for editing NMR spectra by utilizing a soluble gadolinium complex that broadens nuclear spins being at or close to the macromolecule-solvent interface. NOE signals in NOESY spectra are selectively attenuated if surface exposed nuclear spins are involved. HSQC-type spectra with paramagnetic agent contain only signals of the interior of the protein, while the corresponding difference spectra harbor signals allocated to surface spins. Thus, the number of signals can be reduced helping to minimize spectral overlap in large proteins. The method reveals additional information about the localization of spins being helpful for structure determination of large complexes.


Asunto(s)
Espectroscopía de Resonancia por Spin del Electrón/métodos , Resonancia Magnética Nuclear Biomolecular/métodos , Proteínas/química , Gadolinio DTPA/química , Conformación Proteica , Ubiquitina/química
3.
J Biomol Struct Dyn ; 28(1): 13-22, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20476792

RESUMEN

Antibodies have become indispensable reagents with numerous applications in biological and biotechnical analysis, in diagnostics as well as in therapy. In all cases, selective interaction with an epitope is crucial and depends on the conformation of the paratope. While epitopes are routinely mapped at high throughput, methods revealing structural insights on a rather short timescale are rare. We here demonstrate paramagnetic relaxation-enhanced (PRE) NMR spectroscopy to be a powerful tool unraveling structural information about epitope-orientation in a groove spanned by the complementary determining regions. In particular, we utilize the spin label TOAC, which is fused to the peptidic epitope using standard solid-phase chemistry and which is characterized by a reduced mobility compared to, e.g., spin labels attached to the side-chain functionalities of cysteine or lysine residues. We apply the method to determine the orientation of helix 1 of the prion protein, which is the epitope for the therapeutically anti-prion active scF(v) fragment W226.


Asunto(s)
Sitios de Unión de Anticuerpos , Epítopos , Espectroscopía de Resonancia Magnética/métodos , Priones/química , Conformación Proteica , Anticuerpos de Cadena Única/química , Secuencia de Aminoácidos , Modelos Moleculares , Datos de Secuencia Molecular , Priones/inmunología , Alineación de Secuencia , Anticuerpos de Cadena Única/genética , Anticuerpos de Cadena Única/metabolismo , Anticuerpos de Cadena Única/uso terapéutico , Marcadores de Spin
4.
J Biomol Struct Dyn ; 27(2): 163-70, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19583442

RESUMEN

Tricyclic aromatic compounds (TCA) are promising candidates for treatment of transmissible spongiform encephalopathies. Direct binding to the cellular prion protein (PrP(C)) has been proposed as anti-prion active mechanism. We here show by means of NMR-spectroscopy that binding of TCA occurs with millimolar affinity to motifs consisting of two neighboring aromatic residues (Ar-Ar motif). It is independent of the secondary structure of this motif and of the side chain attached to the TCA and it is not specific to PrP(C). Because biologically inactive 9-aminoacridine (9-aa) binds with similar K(D) as anti-prion active quinacrine, direct interaction with PrP(C) as mechanism of action appears highly unlikely. However, binding of 9-aa to Ar-Ar-motifs in proteins can be used as reporter for biological macromolecule interactions, by measuring changes in T(1)-NMR relaxation times of 9-aa.


Asunto(s)
Aminacrina , Sondas Moleculares , Enfermedades por Prión/terapia , Priones , Conformación Proteica , Quinacrina , Aminacrina/química , Aminacrina/metabolismo , Aminacrina/uso terapéutico , Animales , Humanos , Modelos Moleculares , Sondas Moleculares/química , Sondas Moleculares/metabolismo , Sondas Moleculares/uso terapéutico , Estructura Molecular , Resonancia Magnética Nuclear Biomolecular , Priones/química , Priones/genética , Priones/metabolismo , Quinacrina/química , Quinacrina/metabolismo , Quinacrina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA